COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China
Description
As the COVID-19 variant Omicron surge in Beijing, China, a better understanding of risk factors for adverse outcomes may improve clinical management in patients with haematological malignancies (HM) diagnosed with COVID-19. The study sample includes
